← Ишга қайтиш
Ушбу иш иқтибос қилган ишлар
125 та иш
Иш: Therapeutic targeting of cancer stem cell-specific surface glycans and glycoproteins
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
X. Xia, Zongxin Yang, Qisi Lu +6
Шарҳ мақола20242 иқтибосABITargeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
Asha Borah, Sreejith Raveendran, Ankit Rochani +2
Шарҳ мақола20152 иқтибосABIOvercoming Antigen Escape with CAR T-cell Therapy
Hollie J. Jackson, Renier J. Brentjens
Бошқа20152 иқтибосABICirculating tumor cells in neuroblastoma: Current status and future perspectives
Ran Yang, Shan Zheng, Rui Dong
Шарҳ мақола20222 иқтибосABIAffinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects
Yufei Wang, Alicia Buck, Brandon Piel +26
Мақола20242 иқтибосABICancer Stem Cell-targeted Antibody-drug Conjugates for Cancer Immunotherapy
Gyas Khan, Ali Hanbashi, Wedad Mawkili +7
Мақола20252 иқтибосABIThe Investigation of Nfκb Inhibitors to Block Cell Proliferation in OSCC Cells Lines
Yuxi Cheng, Liping Wang, Shuju Zhang +4
Мақола20242 иқтибосABILimits of CD133 as a marker of glioma self‐renewing cells
Virginie Clément, Valérie Dutoit, Denis Marino +2
Мақола20092 иқтибосABIRole of TRPM2 in brain tumours and potential as a drug target
Delphine Ji, Zhengwei Luo, Andrea Ovcjak +4
Шарҳ мақола20212 иқтибосABIAberrant Glycosylation as Biomarker for Cancer: Focus on CD43
Franca Maria Tuccillo, Annamaria de Laurentiis, Camillo Palmieri +8
Шарҳ мақола20142 иқтибосABIBiology and clinical relevance of EpCAM
Laura Keller, Stefan Werner, Klaus Pantel
Шарҳ мақола20192 иқтибосABI